Afuddin tablets were invented by Professor Chang Junbiao of Zhengzhou University and developed by Henan Ruier Biotechnology Co., Ltd., which is the first oral drug of 1. 1 for treating small molecules in COVID-19 in China with completely independent intellectual property rights and global patents. Afuddin tablets were approved to be listed as anti-HIV drugs in July of February1year, and were commissioned by Peking Union Medical College Co., Ltd. to be produced by a real person company.
After the State Administration of Pharmaceutical Products conditionally approved the application for increasing the registration of afudin tablets for the treatment of pneumonia in COVID-19, in order to meet the needs of mass production, real organisation officially started the preparation production.
Significance of putting Afuddin into production
In May, 2002, the Pingdingshan production base of eubios successfully passed the good manufacturing practice compliance inspection organized by the US Food and Drug Administration, which indicated that the company's own production base could produce and manage drugs according to law. The base has a total construction area of 32,000 square meters, and the annual output of preparations in the future can reach 3 billion tablets.
The official production of ASU film is another achievement of the cooperation between government, schools and enterprises, which fills the gap in the production and research of original drugs in the province, and will provide strong support for China's scientific prevention and control of epidemic situation and safeguard people's health, and make contributions to China's early victory over the COVID-19 epidemic in the world.
Reference to the above contents: Zhengzhou University-Professor Chang Junbiao of Zhengzhou University as the inventor, the domestic COVID-19 oral drug Afuddin tablets was officially put into production in Pingdingshan.